Lonza Group, the Switzerland-based bio-pharmaceutical company plans to infuse
$ 150 million (approx Rs 705 crore) in setting up a facility to be located at
the outskirts of Hyderabad, Andhra Pradesh.
The facility is expected to be set up in two phases. Phase I will comprise of
a small-scale multi-purpose manufacturing plant for biopharmaceuticals,
bio-therapeutic media manufacturing plant labs for biologics and bioinformatics
etc. Phase II will see the expanded large-scale manufacturing plant for
biopharmaceuticals and media manufacturing capacity for bio-therapeutic media.
Phase I and Phase II are expected to be completed between 2011-2013 and
2014-2015 respectively.